Fibrinogen is one of the proteins normally present in plasma, and is constantly utilised within the body. In the healthy adult approximately 6 g. are synthesised by the liver and are metabolised each day (Everett, 1946) . Much Fibrinogen was estimated by the following method. To 2 ml. of plasma there were added 30 ml. of 0-9 per cent, sodium chloride and 1 ml. of 2*5 per cent, calcium chloride, and the mixture was incubated overnight at 370 C. The clot which had formed was collected on a fine glass rod and dried on a filter paper, care being taken that none was lost. The nitrogen content was estimated by the micro-kjeldahl method, and the fibrinogen content calculated using the factor 6-25.
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between o-2 and 0-4 g. per cent. In the 10 control cases investigated the results obtained by the method above varied from 0*24 to 0-32 g-
The time after the acute attack at which the patients first came under observation varied widely: thus 3 cases were already in hospital at the time of their coronary occlusion, while, at the other extreme, one patient was not admitted until twenty-two days after the infarct had been sustained.
The cases studied fall into two groups : (a) 32 patients investigated from within one to five days after the onset, and (6) 13 patients admitted between the eighth and twenty-second day after the infarct. In 3?
of the 32 cases in group (a) the plasma showed a rise in fibrinogen content to abnormally high levels during the first or second weeks after the myocardial infarction, the highest recorded level being 0-98 gper cent. From Table I it will be seen that in the majority of cases the * These tubes were prepared by adding 0*5 ml. of 6 per cent, sodium oxalate to each tube and drying them in an oven at ioo? C. till the oxalate remained as a powder* maximum figure lay between 0-50 and 0-79 g. per cent. In the remaining 2 cases of this group the highest levels were at the upper limit of normal, viz., 0*39 and 0-40 g. per cent respectively. Since in these patients the first estimations of fibrinogen were lower, a minor rise did occur. Six patients were examined on the day of the attack, 11 on the second day and 15 between the third and fifth day after the infarct occurred. Of the 6 patients seen on the first day, 3 were examined within three to six hours after the onset and at that time showed normal fibrinogen levels. The other 3 patients
were not examined till ten to seventeen hours had elapsed and these all showed abnormally high levels. Of the 11 patients seen for the first time on the second day, all had plasma fibrinogen levels above the normal range, while of the remaining 15 patients examined for the first time between the third and fifth day after the acute incident, only 3 gave first readings still within the normal range, viz., 0-36 and 0-38 and 0-39 g. per cent. Comparison of the rise in plasma fibrinogen levels with the severity of the coronary thrombosis?the latter being assessed on clinical grounds in all cases by the same physician?-shows that the more severe attacks tend to be associated with the higher levels of fibrinogen in the plasma (Table I) . Determination of blood sedimentation rate was done throughout the course of the illness in all the patients, and it was found that in most cases the B.S.R. changed in a fashion roughly Parallel with the rise and subsequent fall in fibrinogen. The closeness ?f the correlation has not, however, been mathematically examined. Fig-2 (a) patients. The rise in plasma fibrinogen content in the 11 patients described above occurred at a time when, in the group (a) patients, the fibrinogen levels had begun to fall. Some factor other than the myocardial infarct, and common to all cases would therefore appear to be involved. Tromexan administration may be this factor, as all cases were so treated.
Dicoumarol is known to influence fibrinogen production by the liver (Irish and Jaques, 1945) , temporarily stimulating fibrinogen production when administered in moderate dosage, and damping down fibrinogen production when given in massive dosage.
It is therefore possible that tromexan administration in therapeutic dosage may temporarily stimulate fibrinogen production by the liver. This is at present under investigation. In the group (a) patients who received tromexan (24 cases) or dicoumarol (1 case) this effect of the coumarol drug may be overshadowed by the more powerful stimulus of the myocardial infarct. The 7 patients in group (a) who were treated conservatively differed in no respect from those receiving anti-coagulants, except in so far as the maximum level recorded did not exceed ?'79 S-Per cent. The numbers involved are too small to draw definite conclusions.
Summary
An increase in plasma fibrinogen content occurs after myocardial infarction. The maximum increase is detected about one week after the acute episode, and is succeeded by a gradual fall in plasma fibrinogen
